TransMedics Group, Inc. TMDX

Full chart Compare
Set alert

Price alert · TMDX

All alert types
72.76 USD +5.41 (+8.04%)

At closeNov 4, 2026, 7:55 PM EST

72.83 +0.08 +0.10%

After hours · Nov 4, 7:55 PM ET

69.32 Day range 74.63
60.11 52-week range 156.00
YTD
-40.19%
1 year
-40.47%

Financial health

Altman Z-Score

2.36 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B3 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 1
  • P/E 3
  • P/B 2

Valuation

P/E 21.7×
FY 2016: -13.5×FY 2017: -15.5×FY 2018: -18.2×FY 2019: -8.1×FY 2020: -17.2×FY 2021: -12.0×FY 2022: -50.2×FY 2023: -103×FY 2024: 58.3×FY 2025: 21.7×
FY 2016 5y median -12.0× FY 2025
P/S 6.8×
FY 2016: 52.1×FY 2017: 42.1×FY 2018: 33.1×FY 2019: 11.4×FY 2020: 19.2×FY 2021: 17.5×FY 2022: 19.5×FY 2023: 10.6×FY 2024: 4.7×FY 2025: 6.8×
FY 2016 5y median 10.6× FY 2025
P/B 8.7×
FY 2016: 8.3×FY 2017: -1.9×FY 2018: -89.2×FY 2019: 4.9×FY 2020: 4.7×FY 2021: 7.8×FY 2022: 9.7×FY 2023: 18.7×FY 2024: 9.1×FY 2025: 8.7×
FY 2016 5y median 9.1× FY 2025
P/FCF 31.0×
FY 2016: -12.7×FY 2017: -13.9×FY 2018: -16.3×FY 2019: -8.3×FY 2020: -16.0×FY 2021: -16.3×FY 2022: -31.6×FY 2023: -13.4×FY 2024: -25.6×FY 2025: 31.0×
FY 2016 5y median -16.3× FY 2025
EV/EBITDA 27.7×
FY 2016: -14.2×FY 2017: -16.8×FY 2018: -21.9×FY 2019: -10.2×FY 2020: -21.7×FY 2021: -14.2×FY 2022: -58.4×FY 2023: -349×FY 2024: 32.2×FY 2025: 27.7×
FY 2016 5y median -14.2× FY 2025
EV/Sales 6.8×
FY 2016: 51.9×FY 2017: 41.7×FY 2018: 34.1×FY 2019: 12.0×FY 2020: 19.6×FY 2021: 18.1×FY 2022: 18.1×FY 2023: 11.1×FY 2024: 5.1×FY 2025: 6.8×
FY 2016 5y median 11.1× FY 2025
FCF Yield 3.2%
FY 2016: -7.9%FY 2017: -7.2%FY 2018: -6.1%FY 2019: -12.0%FY 2020: -6.2%FY 2021: -6.1%FY 2022: -3.2%FY 2023: -7.5%FY 2024: -3.9%FY 2025: 3.2%
FY 2016 5y median -3.9% FY 2025

Profitability

Gross Margin 59.9%
FY 2016: 12.3%FY 2017: 27.8%FY 2018: 44.1%FY 2019: 58.7%FY 2020: 64.9%FY 2021: 69.9%FY 2022: 69.8%FY 2023: 63.8%FY 2024: 59.4%FY 2025: 59.9%
FY 2016 5y median 63.8% FY 2025
Operating Margin 17.9%
FY 2016: -370.2%FY 2017: -265.8%FY 2018: -155.5%FY 2019: -125.4%FY 2020: -102.9%FY 2021: -130.3%FY 2022: -33.6%FY 2023: -11.9%FY 2024: 8.5%FY 2025: 17.9%
FY 2016 5y median -11.9% FY 2025
Net Margin 31.4%
FY 2016: -387.6%FY 2017: -271.0%FY 2018: -182.5%FY 2019: -142.1%FY 2020: -112.1%FY 2021: -146.1%FY 2022: -38.8%FY 2023: -10.4%FY 2024: 8.0%FY 2025: 31.4%
FY 2016 5y median -10.4% FY 2025
ROE 40.2%
FY 2016: -62.0%FY 2017: 12.3%FY 2018: 492.4%FY 2019: -61.4%FY 2020: -27.7%FY 2021: -65.2%FY 2022: -19.3%FY 2023: -18.2%FY 2024: 15.5%FY 2025: 40.2%
FY 2016 5y median -18.2% FY 2025
ROIC 10.9%
FY 2016: -47.3%FY 2017: -73.2%FY 2018: -68.4%FY 2019: -33.2%FY 2020: -18.8%FY 2021: -35.3%FY 2022: -12.3%FY 2023: -4.1%FY 2024: 5.0%FY 2025: 10.9%
FY 2016 5y median -4.1% FY 2025
ROA 17.8%
FY 2016: -41.4%FY 2017: -56.3%FY 2018: -56.4%FY 2019: -31.9%FY 2020: -18.9%FY 2021: -32.8%FY 2022: -13.1%FY 2023: -3.5%FY 2024: 4.4%FY 2025: 17.8%
FY 2016 5y median -3.5% FY 2025

Growth (YoY)

Revenue 37.1%
FY 2016: 0.0%FY 2017: 23.8%FY 2018: 69.4%FY 2019: 81.3%FY 2020: 8.6%FY 2021: 18.0%FY 2022: 208.8%FY 2023: 158.5%FY 2024: 82.7%FY 2025: 37.1%
FY 2016 FY 2025
Operating Income 189.6%
FY 2016: 0.0%FY 2017: 11.1%FY 2018: 0.9%FY 2019: -46.3%FY 2020: 10.9%FY 2021: -49.4%FY 2022: 20.3%FY 2023: 8.6%FY 2024: 230.5%FY 2025: 189.6%
FY 2016 FY 2025
EPS (diluted) 382.2%
FY 2016: 0.0%FY 2017: 13.3%FY 2018: 14.6%FY 2019: -91.9%FY 2020: 50.8%FY 2021: -37.9%FY 2022: 23.1%FY 2023: 37.4%FY 2024: 231.2%FY 2025: 382.2%
FY 2016 FY 2025
Free Cash Flow 265.0%
FY 2016: 0.0%FY 2017: 8.7%FY 2018: -13.0%FY 2019: -22.9%FY 2020: 5.3%FY 2021: -5.4%FY 2022: -78.3%FY 2023: -232.8%FY 2024: 57.9%FY 2025: 265.0%
FY 2016 FY 2025

Financial Health

Current Ratio 7.1×
FY 2016: 5.9×FY 2017: 3.1×FY 2018: 2.8×FY 2019: 6.2×FY 2020: 12.4×FY 2021: 5.1×FY 2022: 10.7×FY 2023: 9.3×FY 2024: 8.3×FY 2025: 7.1×
FY 2016 5y median 8.3× FY 2025
Quick Ratio 6.6×
FY 2016: 5.2×FY 2017: 2.4×FY 2018: 2.0×FY 2019: 5.5×FY 2020: 11.4×FY 2021: 4.5×FY 2022: 9.8×FY 2023: 8.5×FY 2024: 7.5×FY 2025: 6.6×
FY 2016 5y median 7.5× FY 2025
Debt / Equity 1.0×
FY 2016: 0.2×FY 2017: -0.1×FY 2018: -7.0×FY 2019: 0.6×FY 2020: 0.3×FY 2021: 0.6×FY 2022: 0.4×FY 2023: 3.8×FY 2024: 2.3×FY 2025: 1.0×
FY 2016 5y median 1.0× FY 2025
Net Debt / EBITDA -0.1×
FY 2016: 0.1×FY 2017: 0.2×FY 2018: -0.7×FY 2019: -0.5×FY 2020: -0.4×FY 2021: -0.5×FY 2022: 4.6×FY 2023: -15.7×FY 2024: 2.6×FY 2025: -0.1×
FY 2016 5y median -0.1× FY 2025
Interest Coverage 7.9×
FY 2016: -23.5×FY 2017: -19.1×FY 2018: -8.4×FY 2019: -6.8×FY 2020: -6.6×FY 2021: -10.2×FY 2022: -8.4×FY 2023: -2.7×FY 2024: 2.6×FY 2025: 7.9×
FY 2016 5y median -2.7× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31